|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.80 CHF | -0.37% |
|
-1.82% | -7.08% |
| 11-18 | Bachem, TIRmed Pharma Enter Pharmaceutical Ingredient Manufacturing Partnership | MT |
| 11-03 | Medios Names Successor to Outgoing CEO | MT |
| Capitalization | 4.03B 5.02B 4.31B 3.77B 6.95B 452B 7.57B 46.77B 18.22B 214B 18.85B 18.45B 785B | P/E ratio 2025 * |
34.8x | P/E ratio 2026 * | 22.7x |
|---|---|---|---|---|---|
| Enterprise value | 4.24B 5.28B 4.53B 3.96B 7.31B 475B 7.95B 49.15B 19.15B 225B 19.81B 19.39B 825B | EV / Sales 2025 * |
6.06x | EV / Sales 2026 * | 4.62x |
| Free-Float |
94.31% | Yield 2025 * |
1.7% | Yield 2026 * | 1.8% |
More valuation ratios
* Estimated data
More news
Last Transcript: Bachem Holding AG
More press releases
| 1 day | -0.37% | ||
| 1 week | -1.82% | ||
| Current month | +3.76% | ||
| 1 month | +5.08% | ||
| 3 months | -13.78% | ||
| 6 months | -3.06% | ||
| Current year | -7.08% |
| 1 week | 53.3 |  | 54.55 |
| 1 month | 48.52 | | 56 |
| Current year | 43.34 | | 76 |
| 1 year | 43.34 | | 76 |
| 3 years | 43.34 | | 105.6 |
| 5 years | 43.34 | | 171 |
| 10 years | 9.89 | | 171 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Meier
CEO | Chief Executive Officer | 57 | 31/12/2019 |
Alain Schaffter
DFI | Director of Finance/CFO | 48 | 31/01/2021 |
Ralph Schönleber
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 52 | 12/04/2011 | |
Kuno Sommer
CHM | Chairman | 69 | 24/04/2012 |
Helma Wennemers
BRD | Director/Board Member | 56 | 27/04/2014 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.03% | 0 M€ | -.--% | - |
| 0.03% | 32 M€ | +25.51% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.37% | -1.82% | -17.80% | -37.19% | 5.02B | |
| -0.70% | -2.85% | +2.79% | +17.60% | 47.04B | |
| +2.23% | -1.90% | +9.70% | +6.90% | 37.96B | |
| +1.25% | -4.49% | +72.10% | +63.80% | 35.71B | |
| -0.85% | +1.31% | +11.36% | +16.84% | 27.64B | |
| +3.06% | -2.73% | +63.99% | +172.51% | 15.8B | |
| +0.09% | +0.24% | +64.69% | +227.50% | 15.06B | |
| +2.52% | -1.02% | -13.94% | -4.57% | 14.19B | |
| -1.07% | +0.21% | +66.82% | - | 13.36B | |
| -0.29% | -3.92% | +105.51% | +109.68% | 12.74B | |
| Average | +0.85% | -1.66% | +36.52% | +63.67% | 22.45B | |
| Weighted average by Cap. | +0.77% | -1.91% | +32.61% | +52.71% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 700M 871M 748M 654M 1.21B 78.32B 1.31B 8.11B 3.16B 37.13B 3.27B 3.2B 136B | 972M 1.21B 1.04B 908M 1.67B 109B 1.82B 11.27B 4.39B 51.56B 4.54B 4.44B 189B |
| Net income | 116M 145M 124M 108M 200M 12.99B 218M 1.35B 524M 6.16B 542M 531M 22.6B | 178M 222M 191M 166M 307M 19.95B 334M 2.07B 805M 9.46B 833M 815M 34.7B |
| Net Debt | 206M 256M 220M 192M 354M 23.01B 386M 2.38B 929M 10.91B 961M 940M 40.04B | 458M 571M 490M 428M 790M 51.28B 859M 5.31B 2.07B 24.31B 2.14B 2.1B 89.21B |
More financial data
* Estimated data
Employees
2,292
Calendar
03-11
- Q4 2025 Earnings Call
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 53.80 CHF | -0.37% | 82,141 |
| 09/12/25 | 54.00 CHF | +0.84% | 95,753 |
| 08/12/25 | 53.55 CHF | -1.56% | 109,139 |
| 05/12/25 | 54.40 CHF | +1.40% | 91,207 |
| 04/12/25 | 53.65 CHF | -2.10% | 139,288 |
Delayed Quote Swiss Exchange, December 10, 2025 at 04:31 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
53.80CHF
Average target price
74.89CHF
Spread / Average Target
+39.20%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BANB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition